BioAtla To Be Delisted From Nasdaq Following Listing Council Decision; Trading Suspension Effective August 31, With Shares Expected To Transition To OTC Markets
-SEC Filing
Stocks · News reference
BioAtla shares are trading lower after Nasdaq moved to delist the company, with trading suspended August 31 ahead of a transition to OTC Markets.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — BioAtla, Inc. (BCAB)
Filed: 2026-08-28 AccNo: 0001539497-26-002373 Size: 195 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session. The company's market cap stands at $6.2 million. As per the news, the Q2 earnings report came out 2 days ago.